125 related articles for article (PubMed ID: 37165519)
1. Effect of intralenticular dexamethasone implant: A case report.
Carnevali A; Taloni A; Gatti V; Lamonica L; Oliverio F; Randazzo G; Scorcia V
Eur J Ophthalmol; 2024 Jan; 34(1):NP80-NP83. PubMed ID: 37165519
[TBL] [Abstract][Full Text] [Related]
2. Intracrystalline Ozurdex
Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
Kaldırım H; Savur F; Kırgız A; Atalay K
Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
[TBL] [Abstract][Full Text] [Related]
4. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
6. Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens.
Biswas P; Nandi K; Batra S; Ginodia A; Biswas P
Indian J Ophthalmol; 2018 Jul; 66(7):1033-1036. PubMed ID: 29941766
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema: The OASIS study (a randomised control trial).
Meyer J; Fry C; Turner A; Razavi H
Clin Exp Ophthalmol; 2022 Jul; 50(5):522-533. PubMed ID: 35355382
[TBL] [Abstract][Full Text] [Related]
10. Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
Danis RP; Sadda S; Li XY; Cui H; Hashad Y; Whitcup SM
Br J Ophthalmol; 2016 Jun; 100(6):796-801. PubMed ID: 26581718
[TBL] [Abstract][Full Text] [Related]
11. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion.
Abdolrahimzadeh S; Plateroti P; Scarinci F; Plateroti AM
Acta Ophthalmol; 2016 Dec; 94(8):e810-e811. PubMed ID: 27125991
[No Abstract] [Full Text] [Related]
12. DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification.
Furino C; Boscia F; Niro A; D'Addario M; Grassi MO; Saglimbene V; Reibaldi M; Alessio G
Retina; 2021 May; 41(5):1102-1109. PubMed ID: 32897932
[TBL] [Abstract][Full Text] [Related]
13. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
Ozsaygili C; Duru N
Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
16. Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery.
Lai CC; Kuo SC
BMC Ophthalmol; 2023 Aug; 23(1):352. PubMed ID: 37559002
[TBL] [Abstract][Full Text] [Related]
17. The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema.
Cicinelli MV; Rosenblatt A; Grosso D; Zollet P; Capone L; Rabiolo A; Lattanzio R; Loewenstein A; Bandello F;
Eye (Lond); 2021 Dec; 35(12):3232-3242. PubMed ID: 33479485
[TBL] [Abstract][Full Text] [Related]
18. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
19. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
20. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
